Wolfgang Poeppl1, Heimo Lagler1, Markus Raderer2, Wolfgang R Sperr3, Christoph Zielinski4, Harald Herkner5, Heinz Burgmann6. 1. Clinical Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria. 2. Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria. 3. Clinical Division of Hematology and Hemostasis, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria. 4. Clinical Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria; Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria; Clinical Division of Hematology and Hemostasis, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria. 5. Department of Emergency Medicine, Medical University of Vienna, 1090 Vienna, Austria. 6. Clinical Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria. Electronic address: heinz.burgmann@meduniwien.ac.at.
Abstract
BACKGROUND: Patients with malignancies are at increased risk of serious influenza related complications with higher rates of hospitalization and mortality than healthy cohorts. Although annual vaccination against influenza infection is recommended, vaccination rates among cancer patients are apparently low. The reasons for the low compliance to influenza vaccine and the influenza vaccination rate among Austrian cancer patients have not been studied in detail yet. PATIENTS AND METHODS: From July 1, 2013 to October 31, 2013, 444 patients treated in the outpatient departments of the Clinical Division of Oncology and the Clinical Division of Haematology and Haemostaseology of the General Hospital Vienna participated in a survey on different aspects of influenza vaccination. RESULTS: In total, only 80 out of 444 patients (18%) had received influenza vaccination in the previous year. The influenza vaccination rate was higher amongst patients with haematological malignancies (22%) compared to patients with solid tumours (13%). Higher age was significantly associated with a higher probability for being vaccinated. Collecting information about influenza vaccination primarily from media or the internet was not significantly associated with influenza vaccination status. Information through a medical consultation or a recommendation by the attending physician resulted in significant higher influenza vaccination coverage rates. Only 199 out of the 444 patients (44.8%) were informed by a physician about influenza vaccination and only 18 out of 337 patients (5.3%) with a diagnosis of a malignant disease were informed by their treating oncologist. The main reasons for influenza vaccination denial were concerns about interaction with the malignant disease and potential side-effects. CONCLUSION: Information about influenza vaccination during a medical consultation and a clear recommendation by the attending physician are highly predictive for acceptance of influenza vaccination. Increased awareness among physicians, especially oncologists is of utmost importance to effectively improve IVR in patients with malignant disease.
BACKGROUND:Patients with malignancies are at increased risk of serious influenza related complications with higher rates of hospitalization and mortality than healthy cohorts. Although annual vaccination against influenza infection is recommended, vaccination rates among cancerpatients are apparently low. The reasons for the low compliance to influenza vaccine and the influenza vaccination rate among Austrian cancerpatients have not been studied in detail yet. PATIENTS AND METHODS: From July 1, 2013 to October 31, 2013, 444 patients treated in the outpatient departments of the Clinical Division of Oncology and the Clinical Division of Haematology and Haemostaseology of the General Hospital Vienna participated in a survey on different aspects of influenza vaccination. RESULTS: In total, only 80 out of 444 patients (18%) had received influenza vaccination in the previous year. The influenza vaccination rate was higher amongst patients with haematological malignancies (22%) compared to patients with solid tumours (13%). Higher age was significantly associated with a higher probability for being vaccinated. Collecting information about influenza vaccination primarily from media or the internet was not significantly associated with influenza vaccination status. Information through a medical consultation or a recommendation by the attending physician resulted in significant higher influenza vaccination coverage rates. Only 199 out of the 444 patients (44.8%) were informed by a physician about influenza vaccination and only 18 out of 337 patients (5.3%) with a diagnosis of a malignant disease were informed by their treating oncologist. The main reasons for influenza vaccination denial were concerns about interaction with the malignant disease and potential side-effects. CONCLUSION: Information about influenza vaccination during a medical consultation and a clear recommendation by the attending physician are highly predictive for acceptance of influenza vaccination. Increased awareness among physicians, especially oncologists is of utmost importance to effectively improve IVR in patients with malignant disease.
Authors: Ali Alkan; Ebru Karcı; Arzu Yaşar; Gülseren Tuncay; Elif Berna Köksoy; Muslih Ürün; Filiz Çay Şenler; Ahmet Demirkazık; Güngör Utkan; Hakan Akbulut; Yüksel Ürün Journal: Support Care Cancer Date: 2017-03-22 Impact factor: 3.603
Authors: C T Rieger; B Liss; S Mellinghoff; D Buchheidt; O A Cornely; G Egerer; W J Heinz; M Hentrich; G Maschmeyer; K Mayer; M Sandherr; G Silling; A Ullmann; M J G T Vehreschild; M von Lilienfeld-Toal; H H Wolf; N Lehners Journal: Ann Oncol Date: 2018-06-01 Impact factor: 32.976